BioCentury
ARTICLE | Distillery Therapeutics

Inhibiting ZFYVE28 for insulin resistance

December 4, 2023 3:10 PM UTC

Inhibiting the early endosome-localized zinc finger protein ZFYVE28 could help treat insulin resistance by preventing ZFYVE28’s promotion of phosphorylated insulin receptor degradation and inhibition of insulin receptor recycling.

Compared with non-obese individuals, peripheral blood ZFYVE28 gene expression was lower in insulin-sensitive obese patients, but higher in insulin-resistant obese patients. ZFYVE28 mRNA and protein expression were higher in fat samples from insulin-resistant obese patients than in samples from healthy individuals. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article